Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Bosanquet, Andrew G.
Johnson, Stephen A.
and
Richards, Sue M.
1999.
Prognosis for fludarabine therapy of chronic lymphocytic leukaemia based on ex vivo drug response by DiSC assay.
British Journal of Haematology,
Vol. 106,
Issue. 1,
p.
71.
Kipps, Thomas J.
2000.
Chronic lymphocytic leukemia.
Current Opinion in Hematology,
Vol. 7,
Issue. 4,
p.
223.
Bosanquet, AG
and
Bosanquet, MI
2000.
Ex vivo assessment of drug response by differential staining cytotoxicity (DiSC) assay suggests a biological basis for equality of chemotherapy irrespective of age for patients with chronic lymphocytic leukaemia.
Leukemia,
Vol. 14,
Issue. 4,
p.
712.
Peura, D. A.
2003.
Helicobactor pylori.
p.
489.
Fruehauf, John P.
and
Alberts, David S.
2003.
Chemosensitivity Testing in Oncology.
Vol. 161,
Issue. ,
p.
126.
Hayon, Tamar
Dvilansky, Alexander
Shpilberg, Ofer
and
Nathan, Ilana
2003.
Appraisal of the MTT-based Assay as a Useful Tool for Predicting Drug Chemosensitivity in Leukemia.
Leukemia & Lymphoma,
Vol. 44,
Issue. 11,
p.
1957.
REDAELLI, A.
LASKIN, B.L.
STEPHENS, J.M.
BOTTEMAN, M.F.
and
PASHOS, C.L.
2004.
The clinical and epidemiological burden of chronic lymphocytic leukaemia.
European Journal of Cancer Care,
Vol. 13,
Issue. 3,
p.
279.
Åleskog, Anna
Tobin, Gerard
Laurell, Anna
Thunberg, Ulf
Lindhagen, Elin
Roos, Göran
Nilsson, Kenneth
Nygren, Peter
Sundström, Christer
Höglund, Martin
Larsson, Rolf
and
Rosenquist, Richard
2004.
VH gene mutation status and cellular drug resistance in chronic lymphocytic leukaemia.
European Journal of Haematology,
Vol. 73,
Issue. 6,
p.
407.
??leskog, Anna
Larsson, Rolf
H??glund, Martin
Kristensen, J??rgen
Nygren, Peter
and
Lindhagen, Elin
2005.
In vitro drug resistance in B cell chronic lymphocytic leukemia: a comparison with acute myelocytic and acute lymphocytic leukemia.
Anti-Cancer Drugs,
Vol. 16,
Issue. 3,
p.
277.
Mackey, John R.
Galmarini, Carlos M.
Graham, Kathryn A.
Joy, Anil A.
Delmer, Alain
Dabbagh, Laith
Glubrecht, Darryl
Jewell, Lawrence D.
Lai, Raymond
Lang, Thack
Hanson, John
Young, James D.
Merle-Béral, Helene
Binet, Jacques L.
Cass, Carol E.
and
Dumontet, Charles
2005.
Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations.
Blood,
Vol. 105,
Issue. 2,
p.
767.
Mauskopf, Josephine A
Earnshaw, Stephanie
and
Mullins, C Daniel
2005.
Budget impact analysis: review of the state of the art.
Expert Review of Pharmacoeconomics & Outcomes Research,
Vol. 5,
Issue. 1,
p.
65.
Stephens, Jennifer M
Gramegna, Paola
Laskin, Benjamin
Botteman, Marc F
and
Pashos, Chris L
2005.
Chronic Lymphocytic Leukemia: Economic Burden and Quality of Life.
American Journal of Therapeutics,
Vol. 12,
Issue. 5,
p.
460.
Dodd, R.L.
and
Slevin, N.J.
2006.
Salivary gland adenoid cystic carcinoma: A review of chemotherapy and molecular therapies.
Oral Oncology,
Vol. 42,
Issue. 8,
p.
759.
Kasteng, Frida
Sobocki, Patrik
Svedman, Christer
and
Lundkvist, Jonas
2007.
Economic evaluations of leukemia: A review of the literature.
International Journal of Technology Assessment in Health Care,
Vol. 23,
Issue. 1,
p.
43.
Tsang, Roger Y
Santos, Cheryl
Ghosh, Sunita
Dabbagh, Laith
King, Karen
Young, James
Cass, Carol E
Mackey, John R
and
Lai, Raymond
2008.
Immunohistochemistry for human concentrative nucleoside transporter 3 protein predicts fludarabine sensitivity in chronic lymphocytic leukemia.
Modern Pathology,
Vol. 21,
Issue. 11,
p.
1387.
Hatok, Jozef
Babusikova, Eva
Matakova, Tatiana
Mistuna, Dusan
Dobrota, Dusan
and
Racay, Peter
2009.
In vitro assays for the evaluation of drug resistance in tumor cells.
Clinical and Experimental Medicine,
Vol. 9,
Issue. 1,
p.
1.
Weisenthal, Larry M.
2011.
Cancer Cell Culture.
Vol. 731,
Issue. ,
p.
259.
Lafeuille, Marie-Hélène
Vekeman, Francis
Wang, Si-Tien
Kerrigan, Matthew
Menditto, Laura
and
Duh, Mei Sheng
2012.
Lifetime costs to Medicare of providing care to patients with chronic lymphocytic leukemia.
Leukemia & Lymphoma,
Vol. 53,
Issue. 6,
p.
1146.
Kulesza, Peter
2014.
Cytopathology in Oncology.
Vol. 160,
Issue. ,
p.
273.
Skrepnek, Grant H.
Tate, Wendy R.
and
Baker, Amanda F.
2014.
Clinical and economic burden of Richter syndrome in inpatient cases of chronic lymphocytic leukemia within the United States, 2001–2010.
Leukemia & Lymphoma,
Vol. 55,
Issue. 4,
p.
834.